Kroger Expects To Exceed FY20 Guidance For Adj. Earnings, Same-store Sales

While reporting its financial results for the first quarter on Thursday, Kroger Co. (KR) said it is not reaffirming or providing new guidance for fiscal 2020 due to the difficulty in predicting specific outcomes amid the coronavirus pandemic.

However, Kroger added that while it expects to exceed the outlook shared in its April 1 business update for identical sales without fuel, adjusted FIFO operating profit, adjusted earnings per share and adjusted free cash flow, the company is unable to forecast the extent of such upside.

In April, Kroger had projected fiscal 2020 adjusted earnings in a range of $2.30 to $2.40 per share and adjusted identical sales growth of greater than 2.25 percent.

On average, analysts polled by Thomson Reuters expect the company to report earnings of $2.68 per share for the year. Analysts' estimates typically exclude special items.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
The U.S. Food and Drug Administration approved Boehringer Ingelheim Pharmaceuticals, Inc.'s Pradaxa (dabigatran etexilate) oral blood thinning medication for children. Pradaxa is the first FDA-approved blood thinning medication that children can take by mouth. The only other approved blood thinning medication for children is given by injection. Amazon.com Inc.'s two-day Prime Day event is happening now with more than 2 million deals on offer. The e-commerce giant's biggest shopping extravaganza of the year started June 21 at 3 a.m. EDT and runs for 48 hours, through June 22. Prime Day 2021 will feature the largest number of deals ever offered in the seven year history of the Prime Day Celebrations. New deals are being launched throughout The European Commission announced Tuesday that it has opened a formal antitrust investigation to assess whether Google has violated EU competition rules by favoring its own online display advertising technology services in the so called "ad tech" supply chain, to the detriment of competing providers...
Follow RTT